Finance

Lists
WAZ:FRA
Waters Corp
€350.00
-0.17%
(-0.60) 1D
Aug 25, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for WAZ...
Open
€350.00
High
€350.00
Low
€350.00
Mkt. cap
40.72B
Avg. vol.
13.00
Volume
0.00
52-wk high
€358.60
52-wk low
€243.50
No. of employees
8K
Open
€350.00
High
€350.00
Low
€350.00
Mkt. cap
40.72B
Avg. vol.
13.00
Volume
0.00
52-wk high
€358.60
52-wk low
€243.50
No. of employees
8K
News stories
From web sources and news partners
Profile
Waters Corporation is an American company headquartered in Milford, Massachusetts that provides analytical instruments and software used for chromatography, mass spectrometry, laboratory informatics, and rheometry by the life sciences, materials, and food industries. The company has primary manufacturing facilities in 9 U.S. locations as well as 11 international locations including Wexford, Wilmslow, Birmingham, Hüllhorst, Singapore, Bangalore, Beijing, and Shanghai. Major brands include ACQUITY UPC² / UPLC Systems and columns, Xevo mass spectrometry systems, Synapt MS / HDMS systems, Zodiac HPLC columns, XTerra HPLC columns, XBridge columns, Alliance HPLC systems, Empower chromatography software, MassLynx mass spectrometry software, Oasis sample preparation products, and NuGenesis lab management system. Its primary competitors are Agilent Technologies, Thermo Fisher Scientific, Revvity, and Danaher. Wikipedia
About Waters Corp
CEOUdit Batra
Employees7.9K
Founded1958
HeadquartersMilford, Massachusetts, United States
SectorHealth care
Websitewaters.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Apr 2026
Jul 2026
Revenue
799.89M
932.36M
1.27B
1.64B
Cost of goods sold
327.81M
362.86M
679.00M
757.00M
Cost of revenue
327.81M
362.86M
679.00M
757.00M
Research and development expenses
53.64M
46.90M
95.00M
121.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187.23M
195.78M
305.00M
368.00M
Operating expense
252.97M
254.76M
552.00M
733.00M
Total operating expenses
580.77M
617.62M
1.23B
1.49B
Operating income
219.11M
314.74M
36.00M
155.00M
Other non operating income
-69.00K
2.06M
1.00M
-
EBT including unusual items
170.12M
264.18M
-88.00M
-141.00M
EBT excluding unusual items
197.12M
308.18M
-5.00M
100.00M
Income tax expense
21.20M
38.97M
-16.00M
-5.00M
Effective tax rate
12.46%
14.75%
18.18%
3.55%
Other operating expenses
-
-
-
-
Net income
148.92M
225.21M
-72.00M
-136.00M
Net profit margin
18.62%
24.16%
-5.68%
-8.27%
Earnings per share
3.40
4.53
2.70
3.05
Interest and investment income
4.71M
5.67M
6.00M
5.00M
Interest expense
-26.64M
-14.29M
-48.00M
-60.00M
Net interest expenses
-21.92M
-8.62M
-42.00M
-55.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
271.79M
367.28M
243.00M
456.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps